Prestige Wealth Management Group’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-58
Closed -$1.03K 1136
2022
Q4
$1.03K Buy
+58
New +$1.15K ﹤0.01% 970
2022
Q1
Sell
-43
Closed -$1K 1030
2021
Q4
$1K Buy
+43
New +$1.19K ﹤0.01% 932
2021
Q3
Sell
-18
Closed -$1K 1034
2021
Q2
$1K Buy
18
+7
+64% +$222 ﹤0.01% 913
2021
Q1
$0 Sell
11
-32
-74% -$1.11K ﹤0.01% 1015
2020
Q4
$1K Buy
+43
New +$1.32K ﹤0.01% 878

Other funds holding PETS

Prestige Wealth Management Group's PETS Position: Q1 2023 in Review

Prestige Wealth Management Group sold out of PetMed Express (PETS) in Q1 2023, closing a stake of 58 shares — an estimated $1.03K sold.

Prestige Wealth Management Group first reported a position in PETS in Q4 2020 and held it in 5 quarters. The position peaked at $1.03K in Q4 2022. 165 funds tracked by Wall St. Rank hold PETS as of Q1 2023.

  • Prestige Wealth Management Group reported no remaining PetMed Express position as of Q1 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 58 PetMed Express shares in Q1 2023, an estimated $1.03K.
  • Prestige Wealth Management Group first reported a position in PetMed Express in Q4 2020 and held it in 5 quarters.
  • Prestige Wealth Management Group's PetMed Express position peaked at $1.03K in Q4 2022.
  • 165 funds tracked by Wall St. Rank held PetMed Express as of Q1 2023.

Based on Prestige Wealth Management Group's 13F filing for Q1 2023, filed 16 May 2023.